中国中西医结合杂志2024，Vol.44Issue(12)：1514-1519,6.DOI:10.7661/j.cjim.20230830.060
重视中成药在哮喘防治中的规范化应用
Standardized Application of Chinese Patent Medicine in Treatment of Asthma:Interpretation of the Clinical Application Guidelines of Chinese Patent Medicine for Adults with Bronchial Asthma(2021)
摘要
Abstract
Chinese patent medicine(CPM)has been applied to the treatment of asthma widely and built up richer theoretical and practical experience.However,the clinical application of CPM still suffers from unclear efficacy,safety,application indications,and function characteristics,leading to unreasonable and non-standard usage.Evidence-based effectiveness and safety,the full description of instruction including dosage,course,target user,and usage basing syndrome differentiation are the keys to maximizing the curative effect of CPM.In this context,the National Administration of Traditional Chinese Medicine approved the first evidence-based guideline of Clinical Application Guidelines of CPM for Adults with Bronchial Asthma was released in March 2022.Based on the methodology of guidelines and clinical experience,this paper clarifies the particularity and value of CPM in the management of asthma and put forward the research direction.关键词
哮喘/中成药/指南/解读Key words
asthma/Chinese patent medicine/guidelines/interpretation引用本文复制引用
王建新,林江涛,孙增涛,张洪春,苗青,李秋爽,杨佳慧,孙媛媛..重视中成药在哮喘防治中的规范化应用[J].中国中西医结合杂志,2024,44(12):1514-1519,6.基金项目
国家中医药管理局《中成药治疗优势病种临床应用指南》标准化项目(No.SATCM-2015-BZ402) （No.SATCM-2015-BZ402）
中国中医科学院科技创新工程重大攻关项目(No.CI2021A04701) （No.CI2021A04701）
